WBB Securities Sponsors 19th Annual NewsMakers in the Biotech Industry Conference
Executive Teams of Emerging Biotech Companies to Present to Investor Community
For Immediate Release
September 4, 2012
SAN DIEGO, CA– WBB Securities is a sponsor of The 19th Annual NewsMakers in the Biotech Industry conference. The meeting will be held at the Millennium Broadway Hotel and Conference Center in New York City on Friday, September 7, 2012.
NewsMakers in the Biotech Industry is recognized as the key venue for development-stage biotechnology, medical device and pharmaceutical companies to take their story to Wall Street each fall. NewsMakers anticipates the news by featuring companies with major product and earnings events that promise to be key in the coming years. The objective of the NewsMakers conference is to stimulate interest in a hand-picked group of biotechnology companies whose corporate and regulatory milestones will drive stock prices into 2013 and beyond.
About WBB Securities
WBB Securities is a leading investment management, investment banking, and equity research firm. Established in 2001 and headquartered in San Diego, California, WBB Securities is a registered independent broker dealer and investment advisor with proprietary trading desks that have market-making capabilities. WBB Securities has built a nationwide team of respected senior investment and research professionals with a network of branches throughout the US serving institutional and high net worth clients. The firm also maintains an investment banking and equity research practice focused exclusively in the life sciences niche. www.wbbsec.com
Since 1993, BioCentury Publications, Inc. has been internationally recognized as the leading provider of value-added information, analysis and data for biotechnology and pharmaceutical companies, investors, academia and government on the strategic issues essential to the formation, development and sustainability of life science ventures. BioCentury’s Editorial and Research staff comprise industry-recognized business and science editors and writers. The Company’s management team includes executives with backgrounds in international business, publishing, finance, and the biotech and pharmaceutical industries.